AGEN · Agenus Inc · Metrics
$6.37
-0.36 (-5.35%)
At close · Nov 16
Return incl. dividend (before tax)
Q2 2025 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the timing and completion of these transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the filing date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Nov 5, 2026
Market Cap
$304.51M
Shares
45.25M
Volume · Nov 16
314.12K
Avg daily vol (3M)
962.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
AGEN metrics
96 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$6.73
Market cap
$304.51M
Price action
23 metricsPrice change (1W)
-5.9%
Price change (30D)
+11.4%
Price change (3M)
-8.1%
Price change (6M)
+88.0%
Price change (YTD)
+114.3%
Price change (1Y)
+55.4%
Trailing year
Price change (5Y)
—
52-week high
$9.93
52-week low
$2.77
Change from 52-week high
-32.2%
Change from 52-week low
+143.0%
Annualized volatility
120.7%
Annualized volatility (3M)
89.3%
Implied volatility (30D)
108.1%
IV rank (1Y)
27.5
IV percentile (1Y)
53.3
Beta
1.5
RSI (14D)
46.5
Price vs SMA 50
-8.7%
Price vs SMA 200
+31.7%
Avg volume (3M)
962,634
Relative volume
0.5
Average dollar volume
$7.37M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
45.25M
Valuation
12 metricsP / E (TTM)
6.0
Trailing earnings · reciprocal yield 16.6%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 54.2%
EV / EBITDA
4.6×
reciprocal yield 22.0%
EV / EBIT
4.7×
reciprocal yield 21.1%
P / sales
2.3×
reciprocal yield 44.0%
P / book
—
FCF yield
-34.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
10.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
71.8×
reciprocal yield 1.4%
EV / revenue historical average (3Y)
1.3×
reciprocal yield 79.6%
EV / revenue historical average (5Y)
1.9×
reciprocal yield 53.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
10.7×
reciprocal yield 9.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
8.5×
reciprocal yield 11.8%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-05
Profitability
9 metricsGross margin
100.0%
Operating margin
38.9%
Trailing 12 months
Net margin
23.0%
Gross profit (TTM)
$133.95M
Operating profit (TTM)
$52.15M
Net income (TTM)
$30.75M
Trailing 12 months
Diluted EPS (TTM)
$1.12
FCF margin
-77.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+4.1%
Year over year
Net income growth YoY
-95.7%
Revenue (TTM)
$133.95M
Trailing 12 months
EPS growth YoY
-99.0%
Shares change YoY
+153.4%
Year over year · more shares
Revenue CAGR (3Y)
+5.2%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
12.5%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
$54.36M
Free cash flow (TTM)
−$103.86M
Quick ratio
—
Interest coverage
0.9
Net debt / EBITDA
-1.1
Return on invested capital
—
Trailing 12 months
Net cash
$57.15M
Latest balance sheet
Cash & equivalents
$66.94M
Total assets
$245.55M
Total debt
$29.78M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$103.86M
Capital expenditures (TTM)
$0
R&D (TTM)
$45.74M
SG&A (TTM)
—
Stock compensation (TTM)
$11.11M
R&D / revenue
34.1%
Stock compensation / revenue
8.3%
Ownership (13F)
9 metrics13F filers
104
13F filer change QoQ
+16
Institutional ownership
31.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
6.9%
Private-fund adviser ownership
6.4%
Active holders' share change QoQ
+16.4%
Holder tenure
7.9
Price vs estimated holder cost
-16.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
8.5%
Short interest
3 metricsShort interest
16.8%
Latest settlement · 10.7 days to cover
Days to cover
10.7d
Short-squeeze score
69 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1098972
CUSIP
00847G804
13F (30d)
94 filings
81 filers
Visit website
Investor relations